Gastrointestinal Malignitelerde Fukoz ve Fukozidaz
Küçük Resim Yok
Tarih
1997
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Amaç: Serum glikoproteinlerindeki değişimler malignitelerde karakteristiktir. Son zamanlarda protein bağlı karbonhidratlar kanserde glikoprotein seviyesinin bir göstergesi olarak incelenmektedir. Bu çalışmada, gastrointestinal malignitelerde, L-fukoz ile onun enzimi a-L-fukozidaz’daki değişimleri incelemek amaçlanmıştır. Yöntem: Kontrol (n20), siroz (n20) ve gastrointestinal malignite (n20) gruplarının Proteine bağlı fukoz (PBF) değerleri Dische ve Shettles’in yöntemiyle tayin edildi. M fraksiyonu için Tatsumura’nın ekstraksiyon yöntemi uygulandı. G fraksiyonu totalden M çıkarılarak hesaplandı. a-L-fukozidaz aktivitesi 37 oC’de 1 saatte parçalanan p-nitrofenil a-L-fukozid’in 1 ml’de nanomol cinsinden miktarı şeklinde belirlendi. Total protein biüret yöntemiyle ölçüldü. Bulgular: PBF değerleri kontrol, siroz ve malignite gruplarında sırasıyla 7.331.36, 13.162.88 ve 14.533.25 mg/dl; a-L-fukozidaz değerleri 319.299.5, 463.6215.9 ve 528.5347.3 nmol/ml/saat idi. Total fukoz, G ve M fraksiyonları, fukoz/protein oranı ve a-L-fukozidaz malign grupta, kontrol grubuna göre anlamlı şekilde yüksekti (fukozidaz için p0.02, diğerleri için p0.001). Fakat malign-siroz karşılaştırmasında yalnız total fukoz/protein oranı anlamlı şekilde yüksekti (p0.05). Sensitivite, spesifite ve teşhis doğruluğu yönünden (% 70’in üzerinde) olumlu sonuçlar elde edildi. Sonuç: a-L-fukozidaz ve özellikle fukozun gastrointestinal malignitelerde ümit vaat eden tümör belirteçleri olduğunu tesbit ettik. Bu bulgular malignitede fukoz metabolizmasının daha ileri araştırılması yönünde teşvik edicidir.
Objective: Recently, protein bound carbohydrates have been investigated as indexes of glycoprotein levels in cancer. This study investigates the changes in L-fucose, and its enzyme a-L-fucosidase in gastrointestinal malignancies. Methods: In the control (n20), cirrhotic (n20) and gastrointestinal malignancy (n20) groups, protein bound fucose (PBF) was determined by the Dische and Shettles technique. For its M fraction, the Tatsumura extraction procedure was applied. The G fraction was estimated by subtracting M from total. a-L-fucosidase was estimated as nanomoles of p-nitrophenyl a-L-fucoside, cleaved per ml of serum, per hour at 37 oC. Results: PBF was 7.33±1.36, 13.16±2.88 and 14.53±3.25 mg/dl, a-L-fucosidase was 319.2±99.5, 463.6±215.9 and 528.5±347.3 nmol/ml/h in the control, cirrhotic and malignant groups, respectively. Total fucose, its G and M fractions, fucose/protein ratio and a-L-fucosidase were significantly higher in the malignant group compared to the controls (for the fucosidase p<0.02, for the others p<0.001). However, in the malignant group compared to the cirrhotics, only the total fucose/protein ratio was significantly higher (p<0.05). Satisfactory results (all above 70% ) related to sensitivity, specificity and diagnostic accuracy were also obtained. Conclusion: We conclude that a-L-fucosidase and especially fucose are promising tumor markers in establishing gastrointestinal malignancies. These findings may be a stimulus for further research of fucose metabolism in malignancy.
Objective: Recently, protein bound carbohydrates have been investigated as indexes of glycoprotein levels in cancer. This study investigates the changes in L-fucose, and its enzyme a-L-fucosidase in gastrointestinal malignancies. Methods: In the control (n20), cirrhotic (n20) and gastrointestinal malignancy (n20) groups, protein bound fucose (PBF) was determined by the Dische and Shettles technique. For its M fraction, the Tatsumura extraction procedure was applied. The G fraction was estimated by subtracting M from total. a-L-fucosidase was estimated as nanomoles of p-nitrophenyl a-L-fucoside, cleaved per ml of serum, per hour at 37 oC. Results: PBF was 7.33±1.36, 13.16±2.88 and 14.53±3.25 mg/dl, a-L-fucosidase was 319.2±99.5, 463.6±215.9 and 528.5±347.3 nmol/ml/h in the control, cirrhotic and malignant groups, respectively. Total fucose, its G and M fractions, fucose/protein ratio and a-L-fucosidase were significantly higher in the malignant group compared to the controls (for the fucosidase p<0.02, for the others p<0.001). However, in the malignant group compared to the cirrhotics, only the total fucose/protein ratio was significantly higher (p<0.05). Satisfactory results (all above 70% ) related to sensitivity, specificity and diagnostic accuracy were also obtained. Conclusion: We conclude that a-L-fucosidase and especially fucose are promising tumor markers in establishing gastrointestinal malignancies. These findings may be a stimulus for further research of fucose metabolism in malignancy.
Açıklama
Anahtar Kelimeler
Genel ve Dahili Tıp
Kaynak
Genel Tıp Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
7
Sayı
2
Künye
Çağlayan, O., Ersöz, B., Menteş, G., Osmanoğlu, N., (1997). Gastrointestinal Malignitelerde Fukoz ve Fukozidaz. Genel Tıp Dergisi, 7(2), 89-93.
